THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,299 | -21.7% | 7,103 | -6.0% | 0.00% | – |
| Q2 2023 | $78,246 | -9.3% | 7,560 | -4.9% | 0.00% | – |
| Q1 2023 | $86,279 | -2.3% | 7,952 | +1.1% | 0.00% | – |
| Q4 2022 | $88,279 | +5.1% | 7,868 | -5.0% | 0.00% | – |
| Q3 2022 | $84,000 | +12.0% | 8,280 | 0.0% | 0.00% | – |
| Q2 2022 | $75,000 | -8.5% | 8,280 | -3.1% | 0.00% | – |
| Q1 2022 | $82,000 | +30.2% | 8,548 | +49.5% | 0.00% | – |
| Q4 2021 | $63,000 | +50.0% | 5,718 | 0.0% | 0.00% | – |
| Q3 2021 | $42,000 | -49.4% | 5,718 | 0.0% | 0.00% | – |
| Q2 2021 | $83,000 | -29.1% | 5,718 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $117,000 | +14.7% | 5,718 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $102,000 | +20.0% | 5,718 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $85,000 | +16.4% | 5,718 | +63.6% | 0.00% | 0.0% |
| Q2 2020 | $73,000 | -9.9% | 3,495 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $81,000 | +17.4% | 3,495 | +30.5% | 0.00% | 0.0% |
| Q4 2019 | $69,000 | +32.7% | 2,679 | 0.0% | 0.00% | – |
| Q3 2019 | $52,000 | +18.2% | 2,679 | 0.0% | 0.00% | – |
| Q2 2019 | $44,000 | -27.9% | 2,679 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $61,000 | -11.6% | 2,679 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $69,000 | -21.6% | 2,679 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $88,000 | +44.3% | 2,679 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $61,000 | -6.2% | 2,679 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $65,000 | -13.3% | 2,679 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $75,000 | +31.6% | 2,679 | +61.6% | 0.00% | 0.0% |
| Q3 2017 | $57,000 | -13.6% | 1,658 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $66,000 | +8.2% | 1,658 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $61,000 | +15.1% | 1,658 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $53,000 | -43.6% | 1,658 | -36.4% | 0.00% | 0.0% |
| Q3 2016 | $94,000 | +74.1% | 2,607 | +9.9% | 0.00% | 0.0% |
| Q2 2016 | $54,000 | -85.2% | 2,372 | -79.2% | 0.00% | -90.9% |
| Q2 2014 | $364,000 | – | 11,428 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |